Impaired copulatory behaviour of male @entity35 with XXXX induced by @entity2211 or pituitary grafts.

@entity4089 @entity251 @entity3695 @entity2211 @entity35
Sexually experienced male CFHB @entity35 , castrated and implanted with @entity251 , were chronically treated with @entity2211 (ca. 5 mg/kg/day). Twice-weekly tests of sexual behaviour showed a significant elevation of both mount latency and ejaculation latency, and suppression of mounting rate after 2-3 weeks of treatment. The number of mounts and intromissions before ejaculation was increased on some tests by @entity2211 . Experienced male WAG @entity35 , also castrated and @entity251 implanted, received three pituitary grafts under the kidney capsule. An increase in ejaculation latency was seen during the first week and then again several weeks after grafting, though implantation of non-endocrine tissue (muscle) into the controls may also have affected behaviour. Both treatments elevated serum @entity3695 levels, @entity2211 much more substantially than pituitary grafts. Serum @entity251 levels were sustained within the normal intact range by the implants. The weights of the seminal vesicles, ventral prostate and adrenal glands were not significantly altered by either treatment. These experiments show that @entity4089 induced by two independent methods can retard sexual behaviour in male @entity35 .
